Cargando…

A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2

Rapid identification of the rise and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern remains critical for monitoring of the efficacy of diagnostics, therapeutics, vaccines, and control strategies. A wide range of SARS-CoV-2 next-generation sequencing (NGS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbo, Ellen C., Mourik, Kees, Boers, Stefan A., Munnink, Bas Oude, Nieuwenhuijse, David, Jonges, Marcel, Welkers, Matthijs R. A., Matamoros, Sebastien, van Harinxma thoe Slooten, Joost, Kraakman, Margriet E. M., Karelioti, Evita, van der Meer, David, Veldkamp, Karin Ellen, Kroes, Aloys C. M., Sidorov, Igor, de Vries, Jutte J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075175/
https://www.ncbi.nlm.nih.gov/pubmed/37017810
http://dx.doi.org/10.1007/s10096-023-04590-0
_version_ 1785019867893596160
author Carbo, Ellen C.
Mourik, Kees
Boers, Stefan A.
Munnink, Bas Oude
Nieuwenhuijse, David
Jonges, Marcel
Welkers, Matthijs R. A.
Matamoros, Sebastien
van Harinxma thoe Slooten, Joost
Kraakman, Margriet E. M.
Karelioti, Evita
van der Meer, David
Veldkamp, Karin Ellen
Kroes, Aloys C. M.
Sidorov, Igor
de Vries, Jutte J. C.
author_facet Carbo, Ellen C.
Mourik, Kees
Boers, Stefan A.
Munnink, Bas Oude
Nieuwenhuijse, David
Jonges, Marcel
Welkers, Matthijs R. A.
Matamoros, Sebastien
van Harinxma thoe Slooten, Joost
Kraakman, Margriet E. M.
Karelioti, Evita
van der Meer, David
Veldkamp, Karin Ellen
Kroes, Aloys C. M.
Sidorov, Igor
de Vries, Jutte J. C.
author_sort Carbo, Ellen C.
collection PubMed
description Rapid identification of the rise and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern remains critical for monitoring of the efficacy of diagnostics, therapeutics, vaccines, and control strategies. A wide range of SARS-CoV-2 next-generation sequencing (NGS) methods have been developed over the last years, but cross-sequence technology benchmarking studies have been scarce. In the current study, 26 clinical samples were sequenced using five protocols: AmpliSeq SARS-CoV-2 (Illumina), EasySeq RC-PCR SARS-CoV-2 (Illumina/NimaGen), Ion AmpliSeq SARS-CoV-2 (Thermo Fisher), custom primer sets (Oxford Nanopore Technologies (ONT)), and capture probe-based viral metagenomics (Roche/Illumina). Studied parameters included genome coverage, depth of coverage, amplicon distribution, and variant calling. The median SARS-CoV-2 genome coverage of samples with cycle threshold (Ct) values of 30 and lower ranged from 81.6 to 99.8% for, respectively, the ONT protocol and Illumina AmpliSeq protocol. Correlation of coverage with PCR Ct values varied per protocol. Amplicon distribution signatures differed across the methods, with peak differences of up to 4 log(10) at disbalanced positions in samples with high viral loads (Ct values ≤ 23). Phylogenetic analyses of consensus sequences showed clustering independent of the workflow used. The proportion of SARS-CoV-2 reads in relation to background sequences, as a (cost-)efficiency metric, was the highest for the EasySeq protocol. The hands-on time was the lowest when using EasySeq and ONT protocols, with the latter additionally having the shortest sequence runtime. In conclusion, the studied protocols differed on a variety of the studied metrics. This study provides data that assist laboratories when selecting protocols for their specific setting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10096-023-04590-0.
format Online
Article
Text
id pubmed-10075175
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100751752023-04-06 A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2 Carbo, Ellen C. Mourik, Kees Boers, Stefan A. Munnink, Bas Oude Nieuwenhuijse, David Jonges, Marcel Welkers, Matthijs R. A. Matamoros, Sebastien van Harinxma thoe Slooten, Joost Kraakman, Margriet E. M. Karelioti, Evita van der Meer, David Veldkamp, Karin Ellen Kroes, Aloys C. M. Sidorov, Igor de Vries, Jutte J. C. Eur J Clin Microbiol Infect Dis Original Article Rapid identification of the rise and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern remains critical for monitoring of the efficacy of diagnostics, therapeutics, vaccines, and control strategies. A wide range of SARS-CoV-2 next-generation sequencing (NGS) methods have been developed over the last years, but cross-sequence technology benchmarking studies have been scarce. In the current study, 26 clinical samples were sequenced using five protocols: AmpliSeq SARS-CoV-2 (Illumina), EasySeq RC-PCR SARS-CoV-2 (Illumina/NimaGen), Ion AmpliSeq SARS-CoV-2 (Thermo Fisher), custom primer sets (Oxford Nanopore Technologies (ONT)), and capture probe-based viral metagenomics (Roche/Illumina). Studied parameters included genome coverage, depth of coverage, amplicon distribution, and variant calling. The median SARS-CoV-2 genome coverage of samples with cycle threshold (Ct) values of 30 and lower ranged from 81.6 to 99.8% for, respectively, the ONT protocol and Illumina AmpliSeq protocol. Correlation of coverage with PCR Ct values varied per protocol. Amplicon distribution signatures differed across the methods, with peak differences of up to 4 log(10) at disbalanced positions in samples with high viral loads (Ct values ≤ 23). Phylogenetic analyses of consensus sequences showed clustering independent of the workflow used. The proportion of SARS-CoV-2 reads in relation to background sequences, as a (cost-)efficiency metric, was the highest for the EasySeq protocol. The hands-on time was the lowest when using EasySeq and ONT protocols, with the latter additionally having the shortest sequence runtime. In conclusion, the studied protocols differed on a variety of the studied metrics. This study provides data that assist laboratories when selecting protocols for their specific setting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10096-023-04590-0. Springer Berlin Heidelberg 2023-04-05 2023 /pmc/articles/PMC10075175/ /pubmed/37017810 http://dx.doi.org/10.1007/s10096-023-04590-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Carbo, Ellen C.
Mourik, Kees
Boers, Stefan A.
Munnink, Bas Oude
Nieuwenhuijse, David
Jonges, Marcel
Welkers, Matthijs R. A.
Matamoros, Sebastien
van Harinxma thoe Slooten, Joost
Kraakman, Margriet E. M.
Karelioti, Evita
van der Meer, David
Veldkamp, Karin Ellen
Kroes, Aloys C. M.
Sidorov, Igor
de Vries, Jutte J. C.
A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2
title A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2
title_full A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2
title_fullStr A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2
title_full_unstemmed A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2
title_short A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2
title_sort comparison of five illumina, ion torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of sars-cov-2
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075175/
https://www.ncbi.nlm.nih.gov/pubmed/37017810
http://dx.doi.org/10.1007/s10096-023-04590-0
work_keys_str_mv AT carboellenc acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT mourikkees acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT boersstefana acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT munninkbasoude acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT nieuwenhuijsedavid acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT jongesmarcel acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT welkersmatthijsra acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT matamorossebastien acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT vanharinxmathoeslootenjoost acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT kraakmanmargrietem acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT kareliotievita acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT vandermeerdavid acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT veldkampkarinellen acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT kroesaloyscm acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT sidorovigor acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT devriesjuttejc acomparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT carboellenc comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT mourikkees comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT boersstefana comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT munninkbasoude comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT nieuwenhuijsedavid comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT jongesmarcel comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT welkersmatthijsra comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT matamorossebastien comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT vanharinxmathoeslootenjoost comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT kraakmanmargrietem comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT kareliotievita comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT vandermeerdavid comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT veldkampkarinellen comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT kroesaloyscm comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT sidorovigor comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2
AT devriesjuttejc comparisonoffiveilluminaiontorrentandnanoporesequencingtechnologybasedapproachesforwholegenomesequencingofsarscov2